Maqola

P767Efficacy and safety of switching simvastatin intolerant patients with coronary artery disease to rosuvastatin treatment

Aleksandr B. ShekSpecialized Cardiology Center of the Republic of Uzbekistan, Tashkent, UzbekistanР. Д. КурбановSpecialized Cardiology Center of the Republic of Uzbekistan, Tashkent, UzbekistanG J AbdullaevaSpecialized Cardiology Center of the Republic of Uzbekistan, Tashkent, UzbekistanAleksandr NagaySpecialized Cardiology Center of the Republic of Uzbekistan, Tashkent, UzbekistanShavkat U. HoshimovSpecialized Cardiology Center of the Republic of Uzbekistan, Tashkent, UzbekistanUlugbek NizamovSpecialized Cardiology Center of the Republic of Uzbekistan, Tashkent, Uzbekistan

European Heart Journaljournal2017en

ABI

Annotatsiya

Annotatsiya mavjud emas.

Mavzular

Lipoproteins and Cardiovascular Health Pharmaceutical Economics and Policy Health Systems, Economic Evaluations, Quality of Life

Identifikatorlar

DOI: 10.1093/eurheartj/ehx501.p767

Iqtiboslar va manbalar

0 ta iqtibos0 ta foydalanilgan manba

Koʻrsatkichlar — AkademScholar · Tez orada